Dyne Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $242,162,000.
Profit Margin
| 2014 | 1.46B | -67M | -4.57% |
|---|---|---|---|
| 2015 | 842M | 50M | 5.94% |
| 2016 | 1.36B | -1.24B | -90.78% |
| 2017 | 506M | 76M | 15.02% |
| 2018 | 0 | -4.81M | |
| 2019 | 0 | -13.53M | |
| 2020 | 0 | -58.73M | |
| 2021 | 0 | -149.28M | |
| 2022 | 0 | -165.23M | |
| 2023 | 0 | -235.93M |
DYN Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 506M | 1.36B | 842M | 1.46B |
Cost of revenue | 2.46M | 3.34M | 1.08M | 700K | 271K | 24K | 2.93B | 2.28B | 2.02B | 1.14B |
Gross profit | -2.46M | -3.34M | -1.08M | -700K | -271K | -24K | -2.42B | -915M | -1.18B | 321M |
Operating exp. | ||||||||||
Research and development | 210.76M | 142.76M | 121.30M | 45.2M | 11.04M | 4.27M | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 242.16M | 170.96M | 150.02M | 58.64M | 13.82M | 4.79M | 189M | 161M | 128M | -308M |
Operating income | -242.16M | -170.96M | -150.02M | -58.64M | -13.82M | -4.79M | -412M | -640M | 64M | -318M |
Other income (expenses), net | 6.22M | 2.86M | 734K | -790K | -1.03M | -21K | -126M | -649M | -491M | 50M |
Income before tax | -235.93M | -168.09M | -149.29M | -59.43M | -14.85M | -4.81M | -538M | -1.28B | -427M | -268M |
Income tax expense | 0 | -2.86M | -8K | -700K | -1.32M | -11K | -610M | -45M | -474M | 117M |
Net income | -235.93M | -165.23M | -149.28M | -58.73M | -13.53M | -4.81M | 76M | -1.24B | 50M | -67M |
Earnings per share | ||||||||||
Basic EPS | -3.95 | -3.18 | -2.93 | -4.08 | -0.3 | -0.47 | 0.47 | -9.61 | 0.4 | -0.53 |
Diluted EPS | -3.95 | -3.18 | -2.93 | -4.08 | -0.3 | -0.47 | 0.47 | -9.61 | 0.4 | -0.53 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |